Skip to main content

Turning science into healthcare

Genomics England aims to help everyone benefit from genomic healthcare.

Illustration of people surrounded by circles of data and health icons

GECIP Board

The Genomics England Clinical Interpretation Partnership (GECIP) consists of groups or ‘domains’, overseen by the GECIP Board.

Each domain covers a different disease or topic in the project. The groups are responsible for interpreting the data to improve clinical care, and also undertake complementary research, including medical, computational and social research.

The GECIP Board oversees the operation of GECIP and includes representatives from GECIP funders and the GECIP domains. Up to three places on the GECIP Board are reserved for the representatives of the Participant Panel and they contribute and vote as any other member of the GECIP Board. The individual Participant Panel representatives are free to rotate attendance at the GECIP Board according to their availability.

Professor Dame Kay Davies

Chair of GECIP Board, University of Oxford

Read bio

Mark Bale

Head of Science Partnerships

Read bio

Dr Tom Barlow

Devolved Nations Representative for Scotland

Read bio

Professor Jon Bisson

Devolved Nations Representative for Wales

Read bio

Dr Maria A Cerone

Cancer Research UK

Read bio

Professor Colin Cooper

University of East Anglia

Read bio

Dr Michael Dunn

Wellcome Trust

Read bio

Professor Henry Houlden

University College London

Read bio

Professor Michael Parker

Non-Executive Director; Chair of the Ethics Advisory Committee

Read bio

Professor Dame Sue Hill

NHS England

Read bio

Leanne LeRiche

Participant Panel member

Read bio

Dave McCormick

Participant Panel member

Read bio

Dr Nathan Richardson

Medical Research Council

Read bio

Sir Jonathan Symonds CBE

Non-Executive Director

Read bio

Dr Chrissie Thirlwell

Royal Free Hospital

Read bio

Professor Ian Young

Devolved Nations Representative for Northern Ireland

Read bio

Explore Genomics England